Xilio Therapeutics, Inc. (XLO) › RevenueXilio Therapeutics, Inc. (XLO) — RevenueAnnual figures by fiscal year, from SEC filings.2024: $6.34M2025: $43.77M$43.77M2024Revenue (USD)2025Fiscal YearRevenueChange YoY2025$43.77M+589.9%2024$6.34M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share